An Xu Biotech's announcement on the response to the inquiry letter on the 2023 annual report of the Shanghai Stock Exchange
Minsheng Securities Co., Ltd.'s verification opinion on An Xu Biotech's 2023 Annual Report Information Disclosure Regulatory Inquiry Letter
Response from CCIC Zhonghuan Certified Public Accountants to the inquiry letter on An Xu Biotech's 2023 report
Announcement of Resolutions of Anxu Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Shanghai AllBright Law Firm on An Xu Biotech's 2023 Annual General Meeting of Shareholders
Minsheng Securities Co., Ltd. site inspection report on Hangzhou Anxu Biotechnology Co., Ltd.'s 2023 continuous supervision work site
Anxu Biotech Investor Relations Activity Record Form 20240516
Anxu Biotech's 2023 Annual General Meeting of Shareholders Meeting Materials
An Xu Biotech's announcement on holding the 2023 and first quarter 2024 results briefings
2023 Independent Director Debriefing Report (Chapter Guobao)
2023 Independent Director Debriefing Report (Ma Weimin)
Minsheng Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Hangzhou Anxu Biotechnology Co., Ltd.
Announcement of the 2023 Profit Distribution Plan
Notice on amending the “Articles of Association” and completing registration procedures for industrial and commercial changes
Articles of Association of Hangzhou Anxu Biotechnology Co., Ltd. (202404)
Anxu Biotech Board of Directors Rules of Procedure (202404)
Special Meeting System for Independent Directors (202404)
Announcement on the renewal of the 2024 Audit Institution
Special inspection opinion of Minsheng Securities Co., Ltd. on the deposit and use of funds raised by Hangzhou Anxu Biotechnology Co., Ltd. in 2023
Special report on the storage and actual use of funds raised in 2023
No Data